Medicenna Therapeutics Corp.
NASDAQ:MDNA
0.157 (USD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.134 | 2.812 | 1.586 | 2.945 | 2.362 | 2.411 | 1.191 | 2.907 | 6.269 | 4.349 | 3.701 | 3.18 | 2.176 | 1.813 | 2.135 | 1.659 | 1.246 | 0.828 | 0.661 | 1.276 | 0.446 | 0.635 | 0.864 | 1.352 | 1.07 | 1.805 | 2.045 | 1.598 | 0 | 0 | 0 | 0.001 | 0 | 0 |
| General & Administrative Expenses
| 2.302 | 1.646 | 1.384 | 1.974 | 1.717 | 1.919 | 1.929 | 1.98 | 1.954 | 1.857 | 1.969 | 2.093 | 1.691 | 0.722 | 0.525 | 0.741 | 0.641 | 0.586 | 0.529 | 0.563 | 0.511 | 0.561 | 0.585 | 1.002 | 0.797 | 0.612 | 2.476 | 0.62 | 0.006 | 0.011 | 0.009 | 0 | 0.157 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.302 | 1.646 | 1.384 | 1.974 | 1.717 | 1.919 | 1.929 | 1.98 | 1.954 | 1.857 | 1.969 | 2.093 | 1.691 | 0.722 | 0.525 | 0.741 | 0.641 | 0.586 | 0.529 | 0.563 | 0.511 | 0.561 | 0.585 | 1.002 | 0.797 | 0.612 | 2.476 | 0.62 | 0.006 | 0.011 | 0.009 | 0 | 0.157 | 0.015 |
| Other Expenses
| 0 | 0 | 0.001 | 0.002 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.011 | 0 | -0.007 | 0 | 0 | 0 |
| Operating Expenses
| 5.437 | 4.459 | 2.971 | 4.921 | 4.081 | 4.33 | 3.127 | 4.897 | 8.233 | 6.216 | 5.71 | 5.273 | 3.867 | 2.545 | 2.665 | 2.401 | 1.889 | 1.29 | 1.075 | 1.713 | 0.889 | 1.05 | 1.304 | 2.176 | 1.702 | 2.243 | 4.371 | 2.221 | 0.006 | 0.011 | 0.009 | 0.001 | 0.157 | 0.015 |
| Operating Income
| -6.809 | -5.71 | -1.704 | -8.36 | -7.104 | -4.475 | -3.039 | -4.971 | -8.267 | -6.023 | -5.579 | -5.162 | -3.853 | -2.593 | -2.634 | -2.413 | -1.873 | -1.285 | -1.102 | -1.703 | -0.881 | -1.061 | -1.298 | -2.17 | -1.685 | -2.228 | -4.35 | -2.214 | -0.006 | -0.011 | -0.009 | -0.001 | -0.157 | -0.015 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.086 | 1.597 | -1.537 | 3.78 | 3.837 | 0.175 | -0.079 | 0.09 | 0.055 | -0.17 | -0.104 | -0.065 | 0.081 | 0.193 | -0.024 | 0.012 | -0.015 | -0.005 | 0.026 | -0.01 | -0.008 | 0.011 | -0.006 | -0.005 | -0.016 | -0.013 | -1.769 | 0.042 | -0.011 | 0 | -0.007 | 0.565 | 0.072 | 0 |
| Income Before Tax
| -3.723 | -2.862 | -3.856 | -1.141 | -0.896 | -4.155 | -3.206 | -4.807 | -8.178 | -6.386 | -5.814 | -5.338 | -3.786 | -2.352 | -2.689 | -2.389 | -1.904 | -1.295 | -1.049 | -1.723 | -0.898 | -1.038 | -1.311 | -2.181 | -1.718 | -2.256 | -4.356 | -2.179 | -0.017 | -0.011 | -0.016 | -0.001 | -0.157 | -0.015 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -1.597 | 2.152 | 0.34 | 0.162 | -0.175 | 0.079 | -0.09 | -0.055 | 0.17 | 0.104 | 0.065 | -0.081 | -0.194 | 0.024 | -0.012 | 0.015 | 0.005 | -0.026 | 0.01 | 0.008 | -0.011 | 0.006 | 0.005 | 0.016 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -3.723 | -2.862 | -6.008 | -1.481 | -1.058 | -4.155 | -3.206 | -4.807 | -8.178 | -6.386 | -5.814 | -5.338 | -3.786 | -2.352 | -2.689 | -2.389 | -1.904 | -1.295 | -1.049 | -1.723 | -0.898 | -1.038 | -1.311 | -2.181 | -1.718 | -2.256 | -4.356 | -2.179 | -0.017 | -0.011 | -0.016 | -0.001 | -0.157 | -0.015 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.054 | -0.041 | -0.086 | -0.021 | -0.017 | -0.074 | -0.058 | -0.089 | -0.15 | -0.12 | -0.11 | -0.11 | -0.078 | -0.049 | -0.073 | -0.072 | -0.066 | -0.045 | -0.037 | -0.069 | -0.037 | -0.042 | -0.054 | -0.09 | -0.071 | -0.093 | -0.18 | -1.88 | -0.047 | -0.03 | -0.044 | -0.035 | -0.47 | -0.014 |
| EPS Diluted
| -0.054 | -0.041 | -0.086 | -0.021 | -0.017 | -0.074 | -0.058 | -0.089 | -0.15 | -0.12 | -0.11 | -0.11 | -0.078 | -0.049 | -0.073 | -0.072 | -0.066 | -0.045 | -0.037 | -0.069 | -0.037 | -0.042 | -0.054 | -0.09 | -0.071 | -0.093 | -0.18 | -1.88 | -0.047 | -0.03 | -0.044 | -0.035 | -0.47 | -0.014 |
| EBITDA
| -6.808 | -5.709 | -1.703 | -4.92 | -4.732 | -4.321 | -3.119 | -4.961 | -8.257 | -6.013 | -5.568 | -5.152 | -3.844 | -2.583 | -2.63 | -2.412 | -1.872 | -1.284 | -1.074 | -1.701 | -0.879 | -1.059 | -1.297 | -2.168 | -1.683 | -2.223 | -4.349 | -2.212 | -0.006 | -0.011 | -0.009 | -0.566 | -0.157 | -0.015 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |